EARLY Act Reauthorization of 2025
This legislation continues federal support for nationwide breast and cervical cancer detection, authorizing $235.5 million each year from 2026 through 2030 for screening and diagnostic services. It expands the program to fund patient navigators who help people schedule and access care, with an added focus on reaching communities that face higher cancer rates. The bill also keeps federal breast health education initiatives for young women running through 2031 and orders an independent review to evaluate program access and barriers.
What this bill touches.
Who it helps · who it burdens.
Who it helps
- Individuals at risk of breast and cervical cancerGain continued access to breast health education and outreach, as well as expanded screening, patient navigation, and diagnostic support under reauthorized and expanded federal programs (Sec. 102, Sec. 202(a)(1)).
- National Breast and Cervical Cancer Early Detection Program grant recipientsReceive authorization for $235.5 million annually through fiscal year 2030 and expanded authority to use grant funds for cancer prevention, patient navigation, and barrier-reduction activities (Sec. 202(a)(1), Sec. 202(a)(4)).
Who it burdens
- Grant-funded cancer screening and diagnostic providersMust ensure that screening and diagnostic services funded by program grants align with current evidence-based medical recommendations (Sec. 202(a)(2)).
- Government Accountability OfficeMust conduct a study and report to congressional committees by September 30, 2027, on eligible populations, service trends, and barriers to screening (Sec. 202(b)).
The provisions, in plain language.
Show all 6 provisions
Extends federal funding authorization for breast health education, outreach, and awareness programs for young women through fiscal year 2031.
Expands allowable grant activities under the National Breast and Cervical Cancer Early Detection Program to include cancer prevention, patient navigation, efforts to reduce health disparities, and removing barriers to screening and diagnosis.
Requires grant-funded breast and cervical cancer screening and diagnostic services to align with current evidence-based medical recommendations.
Authorizes $235.5 million per year for fiscal years 2026 through 2030 for the National Breast and Cervical Cancer Early Detection Program.
Shifts the federal program reporting schedule to Congress from every year to every five years, with an initial two-year report due after enactment.
Directs the Government Accountability Office to report to Congress by September 30, 2027, on the number of eligible individuals, participation trends, and barriers to accessing cancer detection services.
Extends federal funding authorization for breast health education, outreach, and awareness programs for young women through fiscal year 2031.
Expands allowable grant activities under the National Breast and Cervical Cancer Early Detection Program to include cancer prevention, patient navigation, efforts to reduce health disparities, and removing barriers to screening and diagnosis.
Requires grant-funded breast and cervical cancer screening and diagnostic services to align with current evidence-based medical recommendations.
Authorizes $235.5 million per year for fiscal years 2026 through 2030 for the National Breast and Cervical Cancer Early Detection Program.
How your members of Congress line up
How members voted on EARLY Act Reauthorization of 2025.
Recorded roll calls on this bill, most recent first. Open one to see each member's position.
How it moved.
Show all 19 actions
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Received in the Senate.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 6 (Roll no. 250). (text: CR H4648)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 6 (Roll no. 250). (text: CR H4648)
- Considered as unfinished business. (consideration: CR H4670-4671)
- At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- DEBATE - The House proceeded with forty minutes of debate on H.R. 4541.
- Considered under suspension of the rules. (consideration: CR H4648-4649)
- Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- Placed on the Union Calendar, Calendar No. 650.
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-746.
- Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- Committee Consideration and Mark-up Session Held
- Forwarded by Subcommittee to Full Committee by Voice Vote.
- Subcommittee Consideration and Mark-up Session Held
- Referred to the Subcommittee on Health.
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 6 (Roll no. 250). (text: CR H4648)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 6 (Roll no. 250). (text: CR H4648)
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-746.
- Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- Introduced in House
Read it for yourself.
Sources & provenance
Cite this page
Civic Herald. “EARLY Act Reauthorization of 2025 (H.R. 4541, 119th Congress).” https://civicherald.app/bills/119-hr-4541. Congress.gov record as of Aug 20, 2026.